NASHNEXT Trademark
NASHNEXT is a USPTO trademark filed by GENFIT. Status: Registered.
Prosecution Summary
Trademark Summary
NASHNEXT is a standard character mark covering diagnostic preparations and chemicals for scientific use in class 1; pharmaceuticals, diagnostic reagents, and biomarker tests for metabolic disorders and liver diseases in class 5; downloadable software and laboratory instruments for diagnostics and data analysis in class 9; medical diagnostic apparatus for metabolic and liver conditions in class 10; biological, clinical, and pharmaceutical research services in class 42; and medical analysis, diagnostic, and information services in class 44. The mark is registered on the Principal Register since June 8, 2021, under registration number 6375856. Owner is GENFIT, a French société anonyme based in Loos, France.
Recent Activity
Filed March 18, 2020, with
Trademark Facts
| Mark | NASHNEXT |
|---|---|
| Serial Number | 88839148 |
| Registration Number | 6375856 |
| Status | Registered |
| Filing Date | 2020-03-18 |
| Registration Date | 2021-06-08 |
| Mark Type | Word |
| Nice Classes | 001 (Chemicals) |
| Owner | GENFIT |
| Attorney of Record | Brooks R. Bruneau |
| Prosecution Events | 15 |
| Latest Event | R.PR on 2021-06-08 |
Goods & Services
Diagnostic preparations for scientific use; Chemical reagents for industrial use, other than for medical or veterinary purpose; Chemical reagents for scientific research purposes | Pharmaceutical preparations for the prevention, diagnosis, monitoring and imaging of metabolic disorders and liver diseases; Diagnostic preparations and diagnostic biomarker reagents for medical purposes; Diagnostic tests for medical use, namely, reagents, nucleotide sequences, enzymes, nucleotides for blood testing, reagents kit, chemical product, biomarking agents, blood and blood derived samples, namely, plasma, serum, platelet free samples | Downloadable software for diagnosis of metabolic disorders and liver diseases and in permitting the transmission and exchange of biological data; scientific and instruments in the nature of laboratory devices for detecting genetic and protein sequences, namely, sequencers, genetic analyser machines, biochips, immunoassays, microfluidic platforms, for detecting genomics/proteomics data, namely, quantitative PCR and readers, for integrating and analyzing the data generated from experimental biology, diseases data and patient clinical data, namely, informatics management system, for recording, quantifying, treating, reproducing, transmitting data, in the field of clinical research and diagnostics of metabolic disorders and liver diseases for use in genetic and enzymatic research | Medical apparatuses for measuring metabolic disorders and liver diseases, non-invasive diagnostic apparatus and instruments for detecting metabolic disorders and liver diseases; Medical diagnostic apparatus, namely, medical devices for diagnosis of metabolic disorders and liver diseases, blood analysis apparatus, DNA and RNA analysis apparatus, gene analyzer, medical devices for measuring the evaluation of metabolic disorders and liver diseases, and blood analysis tools for evaluation of metabolic disorders and liver diseases | Biological research; clinical medical research; computer programming; computer software design for others; Laboratory research services relating to pharmaceuticals in the field of metabolic disorders and liver diseases; industrial research services in the field of pharmaceuticals | Medical analysis services for the diagnosis of liver diseases, metabolic diseases, gastroenterological diseases, inflammatory diseases, immune diseases and cancers; blood sample analysis services; medical assistance services; Medical information in the field of metabolic disorders and liver diseases